Department of Medicine Ultrasonics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China; Department of Cerebrovascular Diseases, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai 519099, China.
Department of Medicine Ultrasonics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China; Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, China.
J Control Release. 2022 Jul;347:369-378. doi: 10.1016/j.jconrel.2022.05.018. Epub 2022 May 18.
Chemo-radiotherapy has been extensively used in clinics, displaying substantial advantages in treatment and prognosis. Stimuli-responsive biodegradable nanoagents that can achieve not only delivery and controlled release of chemotherapeutics, but also hypoxia alleviation to enhance chemoradiotherapy therefore has tremendous potential. Herein, glutathione (GSH)-responsive, biodegradable, doxorubicin-carrying hollow mesoporous organotantalum nanospheres modified with Au and Pt dual nanoenzymes (HMOTP@Pt@Au@Dox) were constructed for chemo-radio sensitization. Degradation of HMOTP@Pt@Au@Dox can be self-activated through GSH stimulation and on-demand release packaged Dox owing to the disulfide bond in the hybrid framework of organotantalum nanospheres. Au and Pt nanoenzymes triggered cascade catalytic reactions that could alleviate hypoxia by utilizing β-d-glucose and HO, thereby sensitizing ROS-based chemoradiotherapy with synergistic starving therapy. Given the radiosensitization of high-Z elements (Ta, Pt, Au), nanoenzymes induced cascade catalytic reaction for hypoxia relief, and the depletion of the predominant antioxidant GSH, desirable tumor suppression could be achieved both in vitro and in vivo, indicating that HMOTP@Pt@Au@Dox is a promising nanoagent to boost chemo-radiotherapy.
化疗-放疗在临床上得到了广泛应用,在治疗和预后方面显示出了显著的优势。刺激响应型可生物降解的纳米制剂不仅可以实现化疗药物的传递和控制释放,还可以缓解缺氧,从而增强化疗-放疗效果,因此具有巨大的潜力。本文构建了载有阿霉素的谷胱甘肽(GSH)响应性、可生物降解的、负载金和铂双纳米酶的空心介孔有机钽纳米球(HMOTP@Pt@Au@Dox),用于化疗-放疗增敏。HMOTP@Pt@Au@Dox 的降解可以通过 GSH 刺激和按需释放封装的 Dox 自激活,这是由于有机钽纳米球的杂化骨架中的二硫键。金和铂纳米酶引发级联催化反应,可以利用β-d-葡萄糖和 HO 缓解缺氧,从而通过协同饥饿疗法增强基于 ROS 的化疗-放疗效果。鉴于高 Z 元素(Ta、Pt、Au)的放射增敏作用、纳米酶诱导的级联催化反应缓解缺氧以及主要抗氧化剂 GSH 的耗竭,HMOTP@Pt@Au@Dox 在体外和体内都可以实现理想的肿瘤抑制,表明 HMOTP@Pt@Au@Dox 是一种有前途的纳米制剂,可增强化疗-放疗效果。